GlassScriptPhysician profile
Tejal Shah
NPI 1346621869
$900.50
in general payments reported to CMS, 2019-2025
13 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.14 · 2020: $86.00 · 2021: $152 · 2022: $231 · 2023: $174 · 2024: $94.21 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $191.76 | 2020-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $148.58 | 2019-2025 | Vaxneuvance, Vaxelis, Rotateq |
| Pfizer INC. | $138.10 | 2020-2023 | |
| Cranial Technologies, INC | $122.22 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $90.95 | 2021-2023 | |
| Alk-Abello, INC | $46.37 | 2025 | Odactra, Ragwitek, Grastek |
| Takeda Pharmaceuticals U.S.A., INC. | $32.87 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $25.14 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $23.71 | 2023 | Aptima |
| Corium, LLC | $21.22 | 2023 | Azstarys |
| Seqirus USA INC | $20.74 | 2022 | |
| Meridian Bioscience INC. | $19.62 | 2020 | |
| Aytu Biopharma, INC. | $19.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.